TD Asset Management Inc

Position in BEAM — Beam Therapeutics Inc.

CIK 1056053 Toronto, A6

Position in BEAM

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,703,144

+$508,493 QoQ

Shares Held

137,038

-22.1% QoQ

Ownership

0.133%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 274 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. BEAM ranks #46 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,703,144	137,038	-22.1%	Shares	Sole	2026-08-04
2026-03-31	$4,194,651	176,024	-8.0%	Shares	Sole	2026-05-11
2025-12-31	$5,301,394	191,248	+31.7%	Shares	Sole	2026-02-10
2025-09-30	$3,523,518	145,180	-6.6%	Shares	Sole	2025-11-10
2025-06-30	$2,643,013	155,380	-26.6%	Shares	Sole	2025-07-28
2025-03-31	$4,136,063	211,780	+14.9%	Shares	Sole	2025-05-07
2024-12-31	$4,570,788	184,306	0.0%	Shares	Sole	2025-02-11
2024-09-30	$4,515,497	184,306	+4.8%	Shares	Sole	2024-11-01
2024-06-30	$4,121,149	175,892	+8.1%	Shares	Sole	2024-08-02
2024-03-31	$5,375,343	162,692	+2167.2%	Shares	Sole	2024-05-08
2020-06-30	$200,928	7,176	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.